- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2021 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
COVID-19
The Rheumatology Network COVID-19 clinical focus page provides information on the latest COVID-19 news, study and clinical trial findings, and clinical guideline updates for the treatment of COVID-19. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for COVID-19 drugs.
Favorable COVID-19 Outcomes in Pregnant Women With Rheumatic Disease
September 16, 2021
COVID-19 has added an additional level of complexity for patients with rheumatic disease who wish to become pregnant.
Perceived Risk of COVID-19 Infection in Patients With Rheumatoid Arthritis
September 13, 2021
“The COVID-19 pandemic has strongly impacted the lives of patients living with rheumatoid arthritis which has contributed to anxiety, depression, and reduced well-being.”
Rheumatology Network Spotlight: COVID-19
September 09, 2021
Catch up on Rheumatology Network's most recent highlights in COVID-19 news.
High Treatment Adherence in Patients With Rheumatic Disease During COVID-19
September 07, 2021
The survey found that 22.3% (n = 62) patients reduced or interrupted treatment and only 3.9% (n = 11) patients stopped treatment entirely. The duration of disease (p = 0.023) and disease activity (p = 0.001) were significant contributing factors in the decision to discontinue treatment.
Fibromyalgia Symptoms More Common in Patients With Postacute COVID-19 Syndrome
September 01, 2021
Clinical features of fibromyalgia are more common in participants who had postacute COVID-19 syndrome.
Rheumatic Disease Does Not Increase Risk of Hospitalization or Death Due to COVID-19
August 26, 2021
Factors that impacted poor outcomes in patients with COVID-19 were closely related to age and comorbidities, not rheumatic disease diagnosis. Increased risk was seen in patients receiving glucocorticoids.
Patients With Fibromyalgia More Susceptible to Psychological Stress During COVID-19 Pandemic
August 25, 2021
The COVID-19 pandemic continues to negatively impact symptom severity, sleep quality, and mood in patients with fibromyalgia.
Patients With Systemic Lupus Erythematosus and COVID-19 Had Higher Risk of Death and Worse Outcomes
August 25, 2021
Results show a significantly higher risk of death and combined poor outcomes compared with patients without lupus and both with and without other comorbidities.
Anakinra Deemed Safe, Anti-inflammatory Drug for Patients With COVID-19
August 18, 2021
Anakinra treatment may reduce mortality risk in patients with moderate-to-severe COVID-19, especially for those with hyperinflammation.
FDA Approves Additional Dose of COVID-19 Vaccine for Immunocompromised Patients
August 16, 2021
The US Food and Drug Administration (FDA) announced it has authorized a third dose of either the Pfizer/BioNTech or Moderna mRNA COVID-19 vaccines for patients with compromised immune systems, such as patients with rheumatic disease.